Onxeo SA
Onxeo SA
-1,95 %
5,540 DKK
-0,11
Kurs
5,540
Hög
5,610
Förändring
-1,95 %
Låg
5,520
Uppdaterad
2019-07-19
Öppen
5,600
Factsheet for Onxeo SA
Company Profile
Description
Onxeo SA is a biotechnology company that is engaged in developing oncology drugs based on tumor DNA targeting. The company focuses on developing disruptive compounds from preclinical research. It produces and develops orphan oncology products under the brand names Livatag, Validive, Beleodaq, platON and AsiDNA.
Key Stats
Website: http://www.onxeo.com
Headquarter country: France
Employees: 54
Market Cap (at close 19-07-2019): DKK 308M
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings
Forward Price/Earnings 6,50
Price/Free Cash Flow
Return on Assets -13,30 -58,10 -17,80 -13,80 -9,10
Return on Equity -19,70 -82,10 -23,00 -17,30 -11,90
Return on Invested Capital -18,40 -81,30 -24,10 -17,60 -11,60
Dividend


Dividend/Share:
Ex. Dividend Date:0001-01-01
Trailing Dividend Yield:
Payout Ratio:0,00
Date Currency Amount
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 6,13 9,51 4,42 3,48 22,08
Gross Profit 0,01 0,01 0,00 0,00 0,02
Gross Margin % 96,49% 93,33% 85,19% 90,32% 98,87%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA -1,00 -25,00 -20,00 -18,00 -1,00
Net income -9,00 -59,00 -23,00 -19,00 -8,00
Basic Earnings Per Share -0,18 -1,17 -0,48 -0,48 -0,19
Operating Income -0,02 -0,07 -0,02 -0,02 0,00
Operating Margin % -255,31% -698,34% -523,67% -636,82% -2,79%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow -11,00 -28,00 -18,00 -23,00 -8,00
Capital Expenditures 0,00 0,00 -1,00 0,00 0,00
Free Cash Flow -11,00 -28,00 -18,00 -23,00 -8,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 20,38 30,86 36,87 41,70 62,95 16,44
Long Term Assets 42,87 47,22 88,23 1,17 89,05 1,30
Total Assets 63,25 78,07 125,10 129,24 152,00 17,74
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 8,39 18,84 12,42 10,61 12,92 6,82
Long Term Liabilities 18,59 15,83
Total Liabilities 31,01 26,44
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings -9,40 -59,07 -22,67 -19,41 -7,70 -15,32
Treasury Stock 0,10 0,09 0,10 0,16 0,12 0,06
Total Stockholder Equity 45,40 49,87 94,09 102,80 121,97 7,44
Net Tangible Assets 6,83 2,34 6,88 102,80 34,04 7,41